Skip to main content
logo
AstraZeneca Pharma India Limited (BOM:506820)
India flag India · Delayed Price · Currency is INR
5,966.05
+43.45 (0.73%)
At close: Oct 16, 2026

AstraZeneca Pharma India Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
149,151193,986215,159133,01081,18363,886
Market Cap Growth
-34.99%-9.84%61.76%63.84%27.07%-15.11%
Enterprise Value
145,781190,335210,362127,86176,55260,484
Last Close Price
5966.057724.928538.845260.873197.332509.29

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
87.93103.45185.9082.3581.76103.71
PS Ratio
6.138.5312.5410.278.097.93
PB Ratio
17.0922.2327.9318.6813.7912.49
P/TBV Ratio
17.0922.2327.9518.7413.7912.49
P/FCF Ratio
--338.25777.38163.1270.07
P/OCF Ratio
--329.19477.25139.2763.38

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
5.998.3612.269.877.637.51
EV/EBITDA Ratio
61.6075.9384.6769.8147.4573.16
EV/EBIT Ratio
68.4781.4397.9374.5851.4387.20
EV/FCF Ratio
--330.71747.29153.8166.33

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.130.130.050.010.010.02
Debt / EBITDA Ratio
0.470.420.140.020.040.10
Debt / FCF Ratio
--0.560.270.140.10
Net Debt / Equity Ratio
-0.39-0.39-0.65-0.70-0.84-0.86
Net Debt / EBITDA Ratio
-1.49-1.34-2.01-2.73-3.06-5.32
Net Debt / FCF Ratio
-20.18-7.87-29.28-9.91-4.82
Asset Turnover
-1.301.321.261.090.99
Inventory Turnover
-1.762.502.872.222.11
Quick Ratio
-0.681.051.891.611.64
Current Ratio
-1.771.912.612.182.12
Return on Equity (ROE)
-22.82%15.62%24.84%18.05%12.73%
Return on Assets (ROA)
-8.33%10.34%10.39%10.11%5.32%
Return on Invested Capital (ROIC)
29.53%43.14%66.13%82.29%131.87%54.86%
Return on Capital Employed (ROCE)
-23.20%26.40%23.80%24.80%13.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
1.14%0.97%0.54%1.21%1.22%0.96%
FCF Yield
-0.11%-0.09%0.30%0.13%0.61%1.43%
Dividend Yield
0.60%0.46%0.37%0.45%0.49%0.39%
Payout Ratio
53.06%42.66%51.84%24.77%20.14%8.12%
Total Shareholder Return
0.63%0.46%0.37%0.45%0.49%0.39%